More articles from Asthma

Association of blood trihalomethane concentrations with asthma in US adolescents: nationally representative cross-sectional study
Yang Sun, Peng-Fei Xia, Jing Xie, Vicente Mustieles, Yu Zhang, Yi-Xin Wang, Carmen Messerlian

European Respiratory Journal May 2022, 59 (5) 2101440; DOI: 10.1183/13993003.01440-2021
Short-acting β₂-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study
Eric D. Bateman, David B. Price, Hao-Chien Wang, Adel Khattab, Patricia Schonffeldt, Angelina Catanzariti, Ralf J.P. van der Valk, Maarten J.H.I. Beekman

European Respiratory Journal May 2022, 59 (5) 2101402; DOI: 10.1183/13993003.01402-2021
A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma
Ritesh Agarwal, Valliappan Muthu, Inderpaul Singh Sehgal, Sahajal Dhooria, Kuruswamy Thurai Prasad, Mandeep Garg, Ashutosh Nath Aggarwal, Arunaloke Chakrabarti

European Respiratory Journal Apr 2022, 59 (4) 2101787; DOI: 10.1183/13993003.01787-2021
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma
John Busby, John G. Matthews, Rekha Chaudhuri, Ian D. Pavord, Timothy C. Hardman, Joseph R. Arron, Peter Bradding, Christopher E. Brightling, David F. Choy, Douglas C. Cowan, Ratko Djukanovic, Catherine E. Hanratty, Tim W. Harrison, Cecile T. Holweg, Peter H. Howarth, Stephen J. Fowler, James L. Lordan, Adel H. Mansur, Andrew Menzies-Gow, Robert M. Niven, Douglas S. Robinson, Samantha M. Walker, Ashley Woodcock, Liam G. Heaney

European Respiratory Journal Apr 2022, 59 (4) 2100768; DOI: 10.1183/13993003.00768-2021
Identification of asthma-associated microRNAs in bronchial biopsies
Mirjam P. Roffel, Ilse M. Boudewijn, Jos L.L. van Nijnatten, Alen Faiz, Corneel J. Vermeulen, Antoon J. van Oosterhout, Karen Affleck, Wim Timens, Ken R. Bracke, Tania Maes, Irene H. Heijink, Corry-Anke Brandsma, Maarten van den Berge

European Respiratory Journal Mar 2022, 59 (3) 2101294; DOI: 10.1183/13993003.01294-2021
Anti-IL5 mepolizumab minimally influences residual blood eosinophils in severe asthma
Glenn Van Hulst, Joseph Jorssen, Nathalie Jacobs, Monique Henket, Renaud Louis, Florence Schleich, Fabrice Bureau, Christophe J. Desmet

European Respiratory Journal Mar 2022, 59 (3) 2100935; DOI: 10.1183/13993003.00935-2021
Novel mechanisms of action contributing to benralizumab's potent anti-eosinophilic activity
Rania Dagher, Varsha Kumar, Alan M. Copenhaver, Sandra Gallagher, Mahboobe Ghaedi, Jonathan Boyd, Paul Newbold, Alison A. Humbles, Roland Kolbeck

European Respiratory Journal Mar 2022, 59 (3) 2004306; DOI: 10.1183/13993003.04306-2020
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
Maria Sparreman Mikus, Johan Kolmert, Lars I. Andersson, Jörgen Östling, Richard G. Knowles, Cristina Gómez, Magnus Ericsson, John-Olof Thörngren, Payam Emami Khoonsari, Barbro Dahlén, Maciej Kupczyk, Bertrand De Meulder, Charles Auffray, Per S. Bakke, Bianca Beghe, Elisabeth H. Bel, Massimo Caruso, Pascal Chanez, Bo Chawes, Stephen J. Fowler, Mina Gaga, Thomas Geiser, Mark Gjomarkaj, Ildikó Horváth, Peter H. Howarth, Sebastian L. Johnston, Guy Joos, Norbert Krug, Paolo Montuschi, Jacek Musial, Ewa Niżankowska-Mogilnicka, Henric K. Olsson, Alberto Papi, Klaus F. Rabe, Thomas Sandström, Dominick E. Shaw, Nikolaos M. Siafakas, Mathias Uhlén, John H. Riley, Stewart Bates, Roelinde J.M. Middelveld, Craig E. Wheelock, Kian Fan Chung, Ian M. Adcock, Peter J. Sterk, Ratko Djukanovic, Peter Nilsson, Sven-Erik Dahlén, Anna James

European Respiratory Journal Feb 2022, 59 (2) 2100142; DOI: 10.1183/13993003.00142-2021
Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index
P. Jane McDowell, John H. Stone, Yuqing Zhang, Kirsty Honeyford, Louise Dunn, R. Jayne Logan, Lorcan P.A. McGarvey, Claire A. Butler, Liam G. Heaney

European Respiratory Journal Jan 2022, 59 (1) 2100160; DOI: 10.1183/13993003.00160-2021
Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)
Wendy C. Moore, Oliver Kornmann, Marc Humbert, Claude Poirier, Elisabeth H. Bel, Norihiro Kaneko, Steven G. Smith, Neil Martin, Martyn J. Gilson, Robert G. Price, Eric S. Bradford, Mark C. Liu

European Respiratory Journal Jan 2022, 59 (1) 2100396; DOI: 10.1183/13993003.00396-2021

Main menu

User menu

Search

More articles from Asthma

Pages

Contact us